Macrophage migration inhibitory factor is associated with aneurysmal expansion

Journal of Vascular Surgery

Volumn 37, Issue 3, 2003, Pages 628-635

  Pan, Jie Hong ^a   Lindholt, Jes S ^b   Sukhova, Galina K ^c   Baugh, John A ^d   Henneberg, Eskild W ^e   Bucala, Richard ^d   Donnelly, Seamas C ^d   Libby, Peter ^c   Metz, Christine ^d   Shi, Guo Ping ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Rigshospitalet   (Denmark)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d PICOWER INST FOR MEDICAL RESEARCH   (United States)

^e VIBORG HOSPITAL   (Denmark)

^f Division of Pulmonary and Critical Care Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ABDOMINAL AORTA ANEURYSM; AORTA; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CELL FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SMOKING HABIT;

EID: 0037344223     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2003.74     Document Type: Article

References (40)

1. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966;153:80-2.
2. Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H, Ohshima T, et al. Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med 1998;4:707-14.
3. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 1999;5:181-91.
4. Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J. Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 2000;275:444-50.
5. Bacher M, Metz CN, Calandra T, Mayer K, Chesney J, Lohoff M, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 1996;93:7849-54.
6. Meyer-Siegler K. Macrophage migration inhibitory factor increases MMP-2 activity in DU-145 prostate cells. Cytokine 2000;12:914-21.
7. Atsumi T, Nishihira J, Makita Z, Koike T. Enhancement of oxidised low-density lipoprotein uptake by macrophages in response to macrophage migration inhibitory factor. Cytokine 2000;12:1553-6.
8. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-72.
9. Lin SG, Yu XY, Chen YX, Huang XR, Metz C, Bucala R, et al. De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res 2000;87:1202-8.
10. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102:576-83.
11. Lindholt JS, Vammen S, Juul S, Henneberg EW, Fasting H. The validity of ultrasonographic scanning as screening method for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 1999;17:472-5.
12. Lindholt JS. Considerations and experiences with screening for abdominal aortic aneurysms. Copenhagen: FADLis Forlag; 1998.
13. Lindholt JS, Henneberg EW, Fasting H, Juul S. Mass or high-risk screening for abdominal aortic aneurysm. Br J Surg 1997;84:40-2.
14. Friedewald WT, Levy RI, Fredrickson DS. Estimation ofthe correlation of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
15. Stabler SP, Lindenbaum J, Savage DG, Allen RH. Elevation of serum cystathinine levels in patients with cobalamin and folate deficiency. Blood 1993;81:3404-13.
16. Moller J, Rasmussen K, Christensen L. External quality assessment of methylmalonic acid and total homocysteine. Clin Chem 1999;45:1536-42.
17. Wiltshire N, Kendrick AH. Evaluation of a new electronic spirometer: the Vitalograph "Escort" spirometer. Thorax 1994;49:175-8.
18. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party: standardization of lung function testing. Eur Respir J Suppl 1993;16:5-40.
19. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000;6:164-70.
20. Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997;3:320-3.
21. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 1999;99:96-104.
22. David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A 1966;56:72-7.
23. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, ct al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
24. Calandra T, Spiegel LA, Metz CN, Bucala R. Macrophage migration inhibitory factor is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria. Proc Nad Acad Sci U S A 1998;95:11383-8.
25. Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, et al. Macrophage migration inhibitory factor (MIF) in rheumatoid arthritis. Arthritis Rheum 1999;42:1601-8.
26. Yamaguchi E, Nishihira J, Shimizu T, Takahashi T, Kitashiro N, Hizawa N, et al. Macrophage migration inhibitory factor (MIF) in bronchial asthma. Clin Exp Allergy 2000;30:1244-9.
27. Kitaichi N, Kotake S, Mizue Y, Matsuda H, Onoe K, Nishihira J. Increase ofmacrophage migration inhibitory factor in sera of patients with iridocyclitis. Br J Ophthalmol 2000;84:1423-5.
28. Lindholt JS, Heickendorff L, Henneberg EW, Fasting H. Serum-elastin-peptides as a predictor of expansion of small AAA. Eur J Vasc Endovasc Surg 1997;14:12-6.
29. Lindholt JS, Heegaard NH, Vammen S, Fasting H, Henneberg EW, Heickendorff L. Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2001;21:51-6.
30. Blann AD, Devine C, Amiral J, McCollum CN. Soluble adhesion molecules, endothelial markers and atherosclerosis risk factors in abdominal aortic aneurysm: a comparison with claudicants and healthy controls. Blood Coagul Fibrinolysis 1998;9:479-84.
31. Szekanecz Z, Shah MR, Harlow LA, Pearce WH, Koch AE. Interleukin-8 and tumor necrosis factor-alpha are involved in human aortic endothelial cell migration. The possible role of these cytokines in human aortic aneurysmal blood vessel growth. Pathobiology 1994;62:134-9.
32. Szekanecz Z, Shah MR, Pearce WH, Koch AE. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation. Agents Actions 1994;42:159-62.
33. Libby P. Changing concepts of atherogenesis. J Intern Med 2000;247:349-58.
34. MacSweeney ST, Powell JT, Greenhalgh RM. Pathogenesis of abdominal aortic aneurysm. Br J Surg 1994;81:935-41.
35. Hirokawa J, Sakaue S, Furuya Y, Ishii J, Hasegawa A, Tagami S, et al. Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes. J Biochem (Tokyo) 1998;123:733-9.
36. Lan HY, Yang N, Metz C, Mu W, Song Q, Nikolic-Paterson DJ, et al. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 1997;3:136-44.
37. Niemann-Jonsson A, Dimayuga P, Jovinge S, Calara F, Ares MP, Fredrikson GN, et al. Accumulation of LDL in rat arteries is associated with activation of tumor necrosis factor-alpha expression. Arterioscler Thromb Vasc Biol 2000;20:2205-11.
38. Davis VA, Persidskaia RN, Baca-Regen LM, Fiotti N, Halloran BG, Baxter BT. Cytokine pattern in aneurysmal and occlusive disease of the aorta. J Surg Res 2001;101:152-6.
39. Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S, et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem 2002;277:7865-74.
40. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc Natl Acad Sci U S A 1995;92:402-6.